Abstract
Summary
Syndromic diagnostic test is a type of medical test that enables the simultaneous detection and identification of multiple pathogens or disease markers associated with a specific syndrome or set of symptoms. Instead of targeting a single pathogen or condition, syndromic tests utilize advanced technologies like multiplex PCR, microarrays, or next-generation sequencing to identify a range of pathogens or genetic markers in a single analysis. These tests are particularly useful in situations where the exact cause of an illness is unknown or when there is a possibility of multiple disease agents contributing to the symptoms.
The global Syndromic Diagnostic Test market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LPI (LP Information)' newest research report, the “Syndromic Diagnostic Test Industry Forecast” looks at past sales and reviews total world Syndromic Diagnostic Test sales in 2023, providing a comprehensive analysis by region and market sector of projected Syndromic Diagnostic Test sales for 2024 through 2030. With Syndromic Diagnostic Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Syndromic Diagnostic Test industry.
This Insight Report provides a comprehensive analysis of the global Syndromic Diagnostic Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Syndromic Diagnostic Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Syndromic Diagnostic Test market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Syndromic Diagnostic Test and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Syndromic Diagnostic Test.
United States market for Syndromic Diagnostic Test is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Syndromic Diagnostic Test is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Syndromic Diagnostic Test is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Syndromic Diagnostic Test players cover Abbott, Hologic, Applied BioCode, Danaher and Diagenode, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Syndromic Diagnostic Test market by product type, application, key players and key regions and countries.
Segmentation by type
Nucleic Acid Extraction Test
Polymerase Chain Reaction (PCR) Test
Others
Segmentation by application
Hospital
Laboratory
Research Institution
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Hologic
Applied BioCode
Danaher
Diagenode
Curetis
Bio-Rad
DiaSorin
bioMérieux
QIAGEN
The global Syndromic Diagnostic Test market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.
LPI (LP Information)' newest research report, the “Syndromic Diagnostic Test Industry Forecast” looks at past sales and reviews total world Syndromic Diagnostic Test sales in 2023, providing a comprehensive analysis by region and market sector of projected Syndromic Diagnostic Test sales for 2024 through 2030. With Syndromic Diagnostic Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Syndromic Diagnostic Test industry.
This Insight Report provides a comprehensive analysis of the global Syndromic Diagnostic Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Syndromic Diagnostic Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Syndromic Diagnostic Test market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Syndromic Diagnostic Test and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Syndromic Diagnostic Test.
United States market for Syndromic Diagnostic Test is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
China market for Syndromic Diagnostic Test is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Europe market for Syndromic Diagnostic Test is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.
Global key Syndromic Diagnostic Test players cover Abbott, Hologic, Applied BioCode, Danaher and Diagenode, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2023.
This report presents a comprehensive overview, market shares, and growth opportunities of Syndromic Diagnostic Test market by product type, application, key players and key regions and countries.
Segmentation by type
Nucleic Acid Extraction Test
Polymerase Chain Reaction (PCR) Test
Others
Segmentation by application
Hospital
Laboratory
Research Institution
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Hologic
Applied BioCode
Danaher
Diagenode
Curetis
Bio-Rad
DiaSorin
bioMérieux
QIAGEN
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Syndromic Diagnostic Test Market Size 2019-2030
2.1.2 Syndromic Diagnostic Test Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Syndromic Diagnostic Test Segment by Type
2.2.1 Nucleic Acid Extraction Test
2.2.2 Polymerase Chain Reaction (PCR) Test
2.2.3 Others
2.3 Syndromic Diagnostic Test Market Size by Type
2.3.1 Syndromic Diagnostic Test Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Syndromic Diagnostic Test Market Size Market Share by Type (2019-2024)
2.4 Syndromic Diagnostic Test Segment by Application
2.4.1 Hospital
2.4.2 Laboratory
2.4.3 Research Institution
2.4.4 Others
2.5 Syndromic Diagnostic Test Market Size by Application
2.5.1 Syndromic Diagnostic Test Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Syndromic Diagnostic Test Market Size Market Share by Application (2019-2024)
3 Syndromic Diagnostic Test Market Size by Player
3.1 Syndromic Diagnostic Test Market Size Market Share by Players
3.1.1 Global Syndromic Diagnostic Test Revenue by Players (2019-2024)
3.1.2 Global Syndromic Diagnostic Test Revenue Market Share by Players (2019-2024)
3.2 Global Syndromic Diagnostic Test Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Syndromic Diagnostic Test by Regions
4.1 Syndromic Diagnostic Test Market Size by Regions (2019-2024)
4.2 Americas Syndromic Diagnostic Test Market Size Growth (2019-2024)
4.3 APAC Syndromic Diagnostic Test Market Size Growth (2019-2024)
4.4 Europe Syndromic Diagnostic Test Market Size Growth (2019-2024)
4.5 Middle East & Africa Syndromic Diagnostic Test Market Size Growth (2019-2024)
5 Americas
5.1 Americas Syndromic Diagnostic Test Market Size by Country (2019-2024)
5.2 Americas Syndromic Diagnostic Test Market Size by Type (2019-2024)
5.3 Americas Syndromic Diagnostic Test Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Syndromic Diagnostic Test Market Size by Region (2019-2024)
6.2 APAC Syndromic Diagnostic Test Market Size by Type (2019-2024)
6.3 APAC Syndromic Diagnostic Test Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Syndromic Diagnostic Test by Country (2019-2024)
7.2 Europe Syndromic Diagnostic Test Market Size by Type (2019-2024)
7.3 Europe Syndromic Diagnostic Test Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Syndromic Diagnostic Test by Region (2019-2024)
8.2 Middle East & Africa Syndromic Diagnostic Test Market Size by Type (2019-2024)
8.3 Middle East & Africa Syndromic Diagnostic Test Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Syndromic Diagnostic Test Market Forecast
10.1 Global Syndromic Diagnostic Test Forecast by Regions (2025-2030)
10.1.1 Global Syndromic Diagnostic Test Forecast by Regions (2025-2030)
10.1.2 Americas Syndromic Diagnostic Test Forecast
10.1.3 APAC Syndromic Diagnostic Test Forecast
10.1.4 Europe Syndromic Diagnostic Test Forecast
10.1.5 Middle East & Africa Syndromic Diagnostic Test Forecast
10.2 Americas Syndromic Diagnostic Test Forecast by Country (2025-2030)
10.2.1 United States Syndromic Diagnostic Test Market Forecast
10.2.2 Canada Syndromic Diagnostic Test Market Forecast
10.2.3 Mexico Syndromic Diagnostic Test Market Forecast
10.2.4 Brazil Syndromic Diagnostic Test Market Forecast
10.3 APAC Syndromic Diagnostic Test Forecast by Region (2025-2030)
10.3.1 China Syndromic Diagnostic Test Market Forecast
10.3.2 Japan Syndromic Diagnostic Test Market Forecast
10.3.3 Korea Syndromic Diagnostic Test Market Forecast
10.3.4 Southeast Asia Syndromic Diagnostic Test Market Forecast
10.3.5 India Syndromic Diagnostic Test Market Forecast
10.3.6 Australia Syndromic Diagnostic Test Market Forecast
10.4 Europe Syndromic Diagnostic Test Forecast by Country (2025-2030)
10.4.1 Germany Syndromic Diagnostic Test Market Forecast
10.4.2 France Syndromic Diagnostic Test Market Forecast
10.4.3 UK Syndromic Diagnostic Test Market Forecast
10.4.4 Italy Syndromic Diagnostic Test Market Forecast
10.4.5 Russia Syndromic Diagnostic Test Market Forecast
10.5 Middle East & Africa Syndromic Diagnostic Test Forecast by Region (2025-2030)
10.5.1 Egypt Syndromic Diagnostic Test Market Forecast
10.5.2 South Africa Syndromic Diagnostic Test Market Forecast
10.5.3 Israel Syndromic Diagnostic Test Market Forecast
10.5.4 Turkey Syndromic Diagnostic Test Market Forecast
10.5.5 GCC Countries Syndromic Diagnostic Test Market Forecast
10.6 Global Syndromic Diagnostic Test Forecast by Type (2025-2030)
10.7 Global Syndromic Diagnostic Test Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Abbott
11.1.1 Abbott Company Information
11.1.2 Abbott Syndromic Diagnostic Test Product Offered
11.1.3 Abbott Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Main Business Overview
11.1.5 Abbott Latest Developments
11.2 Hologic
11.2.1 Hologic Company Information
11.2.2 Hologic Syndromic Diagnostic Test Product Offered
11.2.3 Hologic Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Hologic Main Business Overview
11.2.5 Hologic Latest Developments
11.3 Applied BioCode
11.3.1 Applied BioCode Company Information
11.3.2 Applied BioCode Syndromic Diagnostic Test Product Offered
11.3.3 Applied BioCode Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Applied BioCode Main Business Overview
11.3.5 Applied BioCode Latest Developments
11.4 Danaher
11.4.1 Danaher Company Information
11.4.2 Danaher Syndromic Diagnostic Test Product Offered
11.4.3 Danaher Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Danaher Main Business Overview
11.4.5 Danaher Latest Developments
11.5 Diagenode
11.5.1 Diagenode Company Information
11.5.2 Diagenode Syndromic Diagnostic Test Product Offered
11.5.3 Diagenode Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Diagenode Main Business Overview
11.5.5 Diagenode Latest Developments
11.6 Curetis
11.6.1 Curetis Company Information
11.6.2 Curetis Syndromic Diagnostic Test Product Offered
11.6.3 Curetis Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Curetis Main Business Overview
11.6.5 Curetis Latest Developments
11.7 Bio-Rad
11.7.1 Bio-Rad Company Information
11.7.2 Bio-Rad Syndromic Diagnostic Test Product Offered
11.7.3 Bio-Rad Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Bio-Rad Main Business Overview
11.7.5 Bio-Rad Latest Developments
11.8 DiaSorin
11.8.1 DiaSorin Company Information
11.8.2 DiaSorin Syndromic Diagnostic Test Product Offered
11.8.3 DiaSorin Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 DiaSorin Main Business Overview
11.8.5 DiaSorin Latest Developments
11.9 bioMérieux
11.9.1 bioMérieux Company Information
11.9.2 bioMérieux Syndromic Diagnostic Test Product Offered
11.9.3 bioMérieux Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 bioMérieux Main Business Overview
11.9.5 bioMérieux Latest Developments
11.10 QIAGEN
11.10.1 QIAGEN Company Information
11.10.2 QIAGEN Syndromic Diagnostic Test Product Offered
11.10.3 QIAGEN Syndromic Diagnostic Test Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 QIAGEN Main Business Overview
11.10.5 QIAGEN Latest Developments
12 Research Findings and Conclusion